Bristol Myers Squibb today announced positive top-line results from the ongoing, ex-US, Phase 2 registrational study (NCT05664737) evaluating Reblozyl® (luspatercept-aamt) versus placebo for anemia in ...
Plan your Fetch Charlotte schedule with these lectures to watch.
The study, named IDEAL ( IaDademstat treatment for EssentiAL thrombocythemia ), is a multicenter, single-arm Phase II study to be conducted in Spain in adult patients with ET who are ...
Perioperative enfortumab vedotin plus pembrolizumab and surgery lead to significantly better outcomes among patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based ...
Neurological autoimmune diseases happen when the immune system attacks the central nervous system (CNS) or peripheral nervous system (PNS). This can cause neurological symptoms, and about 30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results